-
1دورية أكاديمية
المؤلفون: Natan Pereira Gosmann (10788387), Marianna de Abreu Costa (10954747), Marianna de Barros Jaeger (10954750), Luis Souza Motta (10954753), Júlia Frozi (10954756), Lucas Spanemberg (739635), Gisele Gus Manfro (7570943), Pim Cuijpers (83464), Daniel Samuel Pine (10954759), Giovanni Abrahão Salum (7570940)
مصطلحات موضوعية: Medicine, Biotechnology, Science Policy, Mental Health, treatment discontinuation rate, acceptability, 3- level approach, PROSPERO, Selective serotonin reuptake inhibitors, assessment instrument, disorder, symptom domains, norepinephrine reuptake inhibitors, CRD, internalizing symptoms, 469 outcome measures, 3- level network meta-analysis, SMD, serotonin reuptake inhibitors, CI, efficacy, SNRI, bias, medication, SSRI, 3- level network meta-analysis Back., MEDLINE, participant, 11 November 2020
-
2دورية أكاديمية
المؤلفون: Natan Pereira Gosmann (10788387), Marianna de Abreu Costa (10954747), Marianna de Barros Jaeger (10954750), Luis Souza Motta (10954753), Júlia Frozi (10954756), Lucas Spanemberg (739635), Gisele Gus Manfro (7570943), Pim Cuijpers (83464), Daniel Samuel Pine (10954759), Giovanni Abrahão Salum (7570940)
مصطلحات موضوعية: Medicine, Biotechnology, Science Policy, Mental Health, treatment discontinuation rate, acceptability, 3- level approach, PROSPERO, Selective serotonin reuptake inhibitors, assessment instrument, disorder, symptom domains, norepinephrine reuptake inhibitors, CRD, internalizing symptoms, 469 outcome measures, 3- level network meta-analysis, SMD, serotonin reuptake inhibitors, CI, efficacy, SNRI, bias, medication, SSRI, 3- level network meta-analysis Back., MEDLINE, participant, 11 November 2020
العلاقة: https://figshare.com/articles/journal_contribution/Study_demographic_information_/14765950Test
-
3دورية أكاديمية
المؤلفون: Natan Pereira Gosmann (10788387), Marianna de Abreu Costa (10954747), Marianna de Barros Jaeger (10954750), Luis Souza Motta (10954753), Júlia Frozi (10954756), Lucas Spanemberg (739635), Gisele Gus Manfro (7570943), Pim Cuijpers (83464), Daniel Samuel Pine (10954759), Giovanni Abrahão Salum (7570940)
مصطلحات موضوعية: Medicine, Biotechnology, Science Policy, Mental Health, treatment discontinuation rate, acceptability, 3- level approach, PROSPERO, Selective serotonin reuptake inhibitors, assessment instrument, disorder, symptom domains, norepinephrine reuptake inhibitors, CRD, internalizing symptoms, 469 outcome measures, 3- level network meta-analysis, SMD, serotonin reuptake inhibitors, CI, efficacy, SNRI, bias, medication, SSRI, 3- level network meta-analysis Back., MEDLINE, participant, 11 November 2020
-
4دورية أكاديمية
المؤلفون: Natan Pereira Gosmann (10788387), Marianna de Abreu Costa (10954747), Marianna de Barros Jaeger (10954750), Luis Souza Motta (10954753), Júlia Frozi (10954756), Lucas Spanemberg (739635), Gisele Gus Manfro (7570943), Pim Cuijpers (83464), Daniel Samuel Pine (10954759), Giovanni Abrahão Salum (7570940)
مصطلحات موضوعية: Medicine, Biotechnology, Science Policy, Mental Health, treatment discontinuation rate, acceptability, 3- level approach, PROSPERO, Selective serotonin reuptake inhibitors, assessment instrument, disorder, symptom domains, norepinephrine reuptake inhibitors, CRD, internalizing symptoms, 469 outcome measures, 3- level network meta-analysis, SMD, serotonin reuptake inhibitors, CI, efficacy, SNRI, bias, medication, SSRI, 3- level network meta-analysis Back., MEDLINE, participant, 11 November 2020
العلاقة: https://figshare.com/articles/journal_contribution/Three-level_model_description_/14765941Test
-
5دورية أكاديمية
المؤلفون: Natan Pereira Gosmann (10788387), Marianna de Abreu Costa (10954747), Marianna de Barros Jaeger (10954750), Luis Souza Motta (10954753), Júlia Frozi (10954756), Lucas Spanemberg (739635), Gisele Gus Manfro (7570943), Pim Cuijpers (83464), Daniel Samuel Pine (10954759), Giovanni Abrahão Salum (7570940)
مصطلحات موضوعية: Medicine, Biotechnology, Science Policy, Mental Health, treatment discontinuation rate, acceptability, 3- level approach, PROSPERO, Selective serotonin reuptake inhibitors, assessment instrument, disorder, symptom domains, norepinephrine reuptake inhibitors, CRD, internalizing symptoms, 469 outcome measures, 3- level network meta-analysis, SMD, serotonin reuptake inhibitors, CI, efficacy, SNRI, bias, medication, SSRI, 3- level network meta-analysis Back., MEDLINE, participant, 11 November 2020
-
6دورية أكاديمية
المؤلفون: Natan Pereira Gosmann (10788387), Marianna de Abreu Costa (10954747), Marianna de Barros Jaeger (10954750), Luis Souza Motta (10954753), Júlia Frozi (10954756), Lucas Spanemberg (739635), Gisele Gus Manfro (7570943), Pim Cuijpers (83464), Daniel Samuel Pine (10954759), Giovanni Abrahão Salum (7570940)
مصطلحات موضوعية: Medicine, Biotechnology, Science Policy, Mental Health, treatment discontinuation rate, acceptability, 3- level approach, PROSPERO, Selective serotonin reuptake inhibitors, assessment instrument, disorder, symptom domains, norepinephrine reuptake inhibitors, CRD, internalizing symptoms, 469 outcome measures, 3- level network meta-analysis, SMD, serotonin reuptake inhibitors, CI, efficacy, SNRI, bias, medication, SSRI, 3- level network meta-analysis Back., MEDLINE, participant, 11 November 2020
-
7دورية أكاديمية
المؤلفون: Natan Pereira Gosmann (10788387), Marianna de Abreu Costa (10954747), Marianna de Barros Jaeger (10954750), Luis Souza Motta (10954753), Júlia Frozi (10954756), Lucas Spanemberg (739635), Gisele Gus Manfro (7570943), Pim Cuijpers (83464), Daniel Samuel Pine (10954759), Giovanni Abrahão Salum (7570940)
مصطلحات موضوعية: Medicine, Biotechnology, Science Policy, Mental Health, treatment discontinuation rate, acceptability, 3- level approach, PROSPERO, Selective serotonin reuptake inhibitors, assessment instrument, disorder, symptom domains, norepinephrine reuptake inhibitors, CRD, internalizing symptoms, 469 outcome measures, 3- level network meta-analysis, SMD, serotonin reuptake inhibitors, CI, efficacy, SNRI, bias, medication, SSRI, 3- level network meta-analysis Back., MEDLINE, participant, 11 November 2020
-
8دورية أكاديمية
المؤلفون: Natan Pereira Gosmann (10788387), Marianna de Abreu Costa (10954747), Marianna de Barros Jaeger (10954750), Luis Souza Motta (10954753), Júlia Frozi (10954756), Lucas Spanemberg (739635), Gisele Gus Manfro (7570943), Pim Cuijpers (83464), Daniel Samuel Pine (10954759), Giovanni Abrahão Salum (7570940)
مصطلحات موضوعية: Medicine, Biotechnology, Science Policy, Mental Health, treatment discontinuation rate, acceptability, 3- level approach, PROSPERO, Selective serotonin reuptake inhibitors, assessment instrument, disorder, symptom domains, norepinephrine reuptake inhibitors, CRD, internalizing symptoms, 469 outcome measures, 3- level network meta-analysis, SMD, serotonin reuptake inhibitors, CI, efficacy, SNRI, bias, medication, SSRI, 3- level network meta-analysis Back., MEDLINE, participant, 11 November 2020
العلاقة: https://figshare.com/articles/journal_contribution/Outcome_assessment_information_/14765956Test
-
9دورية أكاديمية
المؤلفون: Natan Pereira Gosmann (10788387), Marianna de Abreu Costa (10954747), Marianna de Barros Jaeger (10954750), Luis Souza Motta (10954753), Júlia Frozi (10954756), Lucas Spanemberg (739635), Gisele Gus Manfro (7570943), Pim Cuijpers (83464), Daniel Samuel Pine (10954759), Giovanni Abrahão Salum (7570940)
مصطلحات موضوعية: Medicine, Biotechnology, Science Policy, Mental Health, treatment discontinuation rate, acceptability, 3- level approach, PROSPERO, Selective serotonin reuptake inhibitors, assessment instrument, disorder, symptom domains, norepinephrine reuptake inhibitors, CRD, internalizing symptoms, 469 outcome measures, 3- level network meta-analysis, SMD, serotonin reuptake inhibitors, CI, efficacy, SNRI, bias, medication, SSRI, 3- level network meta-analysis Back., MEDLINE, participant, 11 November 2020
العلاقة: https://figshare.com/articles/journal_contribution/Risk_of_bias_in_included_studies_/14765977Test
-
10دورية أكاديمية
المؤلفون: Natan Pereira Gosmann (10788387), Marianna de Abreu Costa (10954747), Marianna de Barros Jaeger (10954750), Luis Souza Motta (10954753), Júlia Frozi (10954756), Lucas Spanemberg (739635), Gisele Gus Manfro (7570943), Pim Cuijpers (83464), Daniel Samuel Pine (10954759), Giovanni Abrahão Salum (7570940)
مصطلحات موضوعية: Medicine, Biotechnology, Science Policy, Mental Health, treatment discontinuation rate, acceptability, 3- level approach, PROSPERO, Selective serotonin reuptake inhibitors, assessment instrument, disorder, symptom domains, norepinephrine reuptake inhibitors, CRD, internalizing symptoms, 469 outcome measures, 3- level network meta-analysis, SMD, serotonin reuptake inhibitors, CI, efficacy, SNRI, bias, medication, SSRI, 3- level network meta-analysis Back., MEDLINE, participant, 11 November 2020